Press releases | eTheRNA engineering RNA

// Stay up to date

Press releases

Follow our progress in developing products that have the potential to transform the future of cancer treatment.

2020

// 15 DECEMBER 2020

eTheRNA immunotherapies & Frame Therapeutics are awarded EUR 1.9 million Eurostars research grant for their novel cancer vaccine collaboration

// 1 DECEMBER 2020

eTheRNA and China Grand Pharma enter a strategic collaboration in the Greater China Region focused on eTheRNA’s proprietary mRNA development products and manufacturing capabilities

// 3 NOVEMBER 2020

eTheRNA extends mRNA contract manufacturing services

// 8 OCTOBER 2020

eTheRNA extends senior management team with appointment of Michael Mulqueen as VP Business Development

// 16 JUNE 2020

eTheRNA raises EUR 34 million in Series B financing to accelerate multiple mRNA therapeutic development programs through to clinical proof of concept

// 22 APRIL 2020

Frame Therapeutics and eTheRNA immunotherapies NV open a new research collaboration to develop mRNA cancer vaccines against immunogenic neoantigens

// 24 MARCH 2020

eTheRNA Launches an International Consortium and Starts Development of Cross-strain Protective CoV-2 mRNA Vaccine for High Risk Populations